LeonaBio, Inc. (LONA)

LeonaBio Statistics

Total Valuation

LeonaBio has a market cap or net worth of $105.96 million. The enterprise value is $19.37 million.

Market Cap	105.96M
Enterprise Value	19.37M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

LeonaBio has 9.34 million shares outstanding. The number of shares has increased by 11.11% in one year.

Current Share Class	9.34M
Shares Outstanding	9.34M
Shares Change (YoY)	+11.11%
Shares Change (QoQ)	+35.53%
Owned by Insiders (%)	5.70%
Owned by Institutions (%)	41.99%
Float	6.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.18
P/TBV Ratio	3.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.06.

Current Ratio	1.43
Quick Ratio	1.41
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -290.81% and return on invested capital (ROIC) is -169.11%.

Return on Equity (ROE)	-290.81%
Return on Assets (ROA)	-84.70%
Return on Invested Capital (ROIC)	-169.11%
Return on Capital Employed (ROCE)	-346.29%
Weighted Average Cost of Capital (WACC)	16.24%
Revenue Per Employee	n/a
Profits Per Employee	-$4.06M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +320.37% in the last 52 weeks. The beta is 2.23, so LeonaBio's price volatility has been higher than the market average.

Beta (5Y)	2.23
52-Week Price Change	+320.37%
50-Day Moving Average	6.63
200-Day Moving Average	4.95
Relative Strength Index (RSI)	69.98
Average Volume (20 Days)	94,010

Short Selling Information

The latest short interest is 44,014, so 0.47% of the outstanding shares have been sold short.

Short Interest	44,014
Short Previous Month	36,594
Short % of Shares Out	0.47%
Short % of Float	0.69%
Short Ratio (days to cover)	0.76

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-102.27M
Pretax Income	-105.61M
Net Income	-105.61M
EBITDA	-101.29M
EBIT	-102.27M
Earnings Per Share (EPS)	-$24.70

Balance Sheet

The company has $88.33 million in cash and $1.74 million in debt, with a net cash position of $86.59 million or $9.27 per share.

Cash & Cash Equivalents	88.33M
Total Debt	1.74M
Net Cash	86.59M
Net Cash Per Share	$9.27
Equity (Book Value)	27.79M
Book Value Per Share	5.20
Working Capital	26.84M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	972,000
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LeonaBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.11%
Shareholder Yield	-11.11%
Earnings Yield	-99.67%
FCF Yield	n/a

Analyst Forecast

The average price target for LeonaBio is $10.00, which is -11.89% lower than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	-11.89%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 18, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Sep 18, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a